In vitro evaluation of modified release formulations of nifedipine from Indian market
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Poster
- By: PANCHAGNULA, Ramesh (University of Ulster, Coleraine, United Kingdom)
- Co-author(s): Ramnik Singh (NIPER, MOHALI, India)
Ashokraj (NIPER, MOHALI, India)
Nifedipine, an important therapeutic agent in the management of cardiovascular disorder is recommended to administer as modified release dosage form in order to avoid the fluctuations in blood levels. An in vitro evaluation of modified release formulations, marketed in India was conducted and compared their performance with a novel matrix based.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.